Study shows that some of the genetic changes in cats tumors resemble closely to those found in human cancers. These parallels open new perspectives for developing targeted cancer therapies, particularly for breast cancer.

While reviewing lung cancer CT scans, doctors sometimes spot abnormalities unrelated to the lungs. New research has now shown that some of those abnormalities could be signs of other undiagnosed cancers.

Scientists have revealed that a drug that is widely used to treat asthma and allergies may also help fight aggressive cancers. The findings suggest that it is a new way to improve treatment for tough tumors, such as triple-negative breast cancer, where immunotherapy often fails.

Gene editing could help solve one of the biggest problems in treating aggressive blood cancers: how to attack cancer cells without destroying healthy donor cells. A new multicentre trial shows that CRISPR-modified stem cell transplants may make CD33-targeted therapies safer and more effective after transplantation.

A recent study has revealed that valvular heart disease is common in cancer patients and that interventions to treat this disease significantly improved survival.

The ‘Cardiocare’ project is focusing on a vulnerable group of patients – women over 65 with breast cancer at risk of cardiotoxicity from cancer treatment. The project is currently celebrating a series of major achievements that bring its ambitious vision closer to reality: smarter, more personalized and more patient-centered care for this patient group.

Researchers have developed a high-throughput method to identify gold nanoparticles capable of delivering therapies directly to the mitochondria, the energy centres inside cancer cells.

A new poll by the Physicians Committee for Responsible Medicine has found out that almost half of the adults in the USA are not aware that eating processed meat increases colon cancer risk. On the other hand, research says that plant-based diet reduces the risk by 22 %.

Creatine, the organic acid that is popularly taken as a supplement by athletes and bodybuilders, supercharges a critical class of immune cells that activate and prepare the body’s key cancer-fighters, according to new UCLA research.

Researchers have developed a new drug – elraglusib that may help pancreatic cancer patients to live longer. A phase 2 randomized trial showed that the drug along with chemotherapy reduced the risk of death by 38 %.